GlassScriptPhysician profile
Mark M Kirkham
NPI 1033118732
$1,871.94
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $124 · 2021: $273 · 2022: $376 · 2023: $415 · 2024: $23.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $263.18 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $257.68 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $181.71 | 2019-2023 | |
| Amgen INC. | $161.04 | 2019-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.60 | 2021-2023 | Jardiance |
| Atricure, INC. | $118.61 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.99 | 2019-2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $84.43 | 2021-2023 | Opsumit, Uptravi |
| Braemar Manufacturing, LLC | $68.54 | 2019 | |
| Bardy Diagnostics, INC. | $65.00 | 2019-2020 | |
| Amarin Pharma, INC. | $64.11 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $62.60 | 2022-2023 | Verquvo |
| Pfizer INC. | $52.71 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.96 | 2019-2022 | |
| Daiichi Sankyo INC. | $43.35 | 2021-2023 | Injectafer |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $34.52 | 2020 | |
| Lundbeck LLC | $31.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $27.92 | 2019-2023 | Farxiga |
| Gilead Sciences, INC. | $13.14 | 2019 | |
| Philips North America LLC | $13.06 | 2020 | |
| Chiesi USA, INC. | $11.87 | 2022 | |
| Terumo Medical Corporation | $11.57 | 2019 | |
| Tactile Systems Technology INC | $11.36 | 2019 | |
| Teleflex LLC | $11.14 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kirkham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.